GeneFerm Biotechnology Market Cap

GeneFerm Biotechnology has a market cap or net worth of 1.81 billion as of February 13, 2026. Its market cap has decreased by -1.91% in one year.

Market Cap

1.81B

Enterprise Value

1.87B

Revenue

654.88M

Ranking

n/a

PE Ratio

112.85

Stock Price

43.75

Market Cap Chart

Since July 26, 2016, GeneFerm Biotechnology's market cap has decreased from 2.17B to 1.81B, a decrease of -16.57%. That is a compound annual growth rate of -1.88%.

Market Cap History

Date	Market Cap	% Change
Feb 11, 2026	1.81B	-9.33%
Dec 31, 2025	2.00B	2.66%
Dec 31, 2024	1.95B	-36.91%
Dec 29, 2023	3.09B	11.36%
Dec 30, 2022	2.77B	53.32%
Dec 30, 2021	1.81B	122.87%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Jul 26, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PhytoHealth	2.82B
Golden Biotechnology	2.73B
Johnson Chemical Pharmaceutical Works	2.56B
LIWANLI Innovation	2.51B
Allied Biotech	2.38B
TSH Biopharm Corporation	2.17B
Tien Liang BioTech	1.75B
InnoPharmax	1.71B

Market Cap Rankings